Essex, United Kingdom

David John Virley

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Location History:

  • Harlow, GB (2015)
  • Essex, GB (2017)

Company Filing History:


Years Active: 2015-2017

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of David John Virley

Introduction

David John Virley is a notable inventor based in Essex, GB, recognized for his contributions to the field of pharmaceuticals. With a total of two patents to his name, he has made significant strides in developing therapeutic agents that hold promise for various medical applications.

Latest Patents

Virley's latest patents include innovative combinations involving 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline. This compound, or its pharmaceutically acceptable salt, is combined with a second therapeutic agent, which is selected from a range of options. These patents highlight the potential use of 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline for the treatment of various conditions, showcasing his commitment to advancing medical science.

Career Highlights

Currently, David John Virley is associated with Axovant Sciences GmbH, where he continues to push the boundaries of pharmaceutical innovation. His work at this company reflects his dedication to improving healthcare through research and development.

Collaborations

Throughout his career, Virley has collaborated with esteemed colleagues, including Tsu Tshen Chuang and Ann Jacqueline Hunter. These partnerships have likely contributed to the success of his projects and the advancement of their shared goals in the pharmaceutical industry.

Conclusion

David John Virley exemplifies the spirit of innovation in the pharmaceutical field, with his patents and collaborations paving the way for future advancements. His work continues to impact the industry positively, demonstrating the importance of research and development in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…